KDR and neoplasm: As its contribution to the growth and invasion of tumors (Zhao and Adjei 2015), VEGF/VEGFR pathway is brought to inhibition treatment, leading to rapid and long-lasting anti-angiogenesis and anti-tumor responses (Carmeliet and Jain 2011).